'Genetically engineered proteins derived' presentation slideshows

Biologics and Biosimilars Market Demand Increases Cause Of New Advancement

Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Moreover, these drugs are approved by FDA due to their similar therapeutical actions as biologics. Request for sample copy @ https://goo.gl/uX9D4j The major factors that contribute to the growth of the biologics and biosimilars market include increase in the prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and rise in geriatric population. Moreover, large numbers of clinical trials and innovative R&D approaches to develop advanced drugs drive the market growth. However, manufacturing difficulties due to complexity of drug molecules hinder the market growth. Increase in R&D activities in the field of pharma.

172 views • 7 slides